Viewing StudyNCT00017290



Ignite Creation Date: 2024-05-05 @ 11:22 AM
Last Modification Date: 2024-10-26 @ 9:06 AM
Study NCT ID: NCT00017290
Status: UNKNOWN
Last Update Posted: 2013-12-04
First Post: 2001-06-06

Brief Title: Combination Chemotherapy Followed By Vaccine Therapy Plus Sargramostim in Treating Patients With Stage III or Stage IV Non-Hodgkins Lymphoma
Sponsor: Genitope Corporation
Organization: National Cancer Institute NCI

Organization Data

Organization: National Cancer Institute NCI
Class: NIH
Study ID: CDR0000068673
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Genitope Corporation
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators